Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.050
+0.030 (1.49%)
At close: Mar 9, 2026, 4:00 PM EDT
2.060
+0.010 (0.49%)
Pre-market: Mar 10, 2026, 7:59 AM EDT
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,581,000
Market Cap
7.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -20 | -90.91% | 2 | 0 |
| Dec 31, 2023 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2022 | 29 | 4 | 16.00% | 28 | 1 |
| Dec 31, 2021 | 25 | 3 | 13.64% | 24 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| KALA BIO | 38 |
| Kiora Pharmaceuticals | 12 |
| Alzamend Neuro | 7 |
| Immuron | 7 |
| Ernexa Therapeutics | 6 |
| Addex Therapeutics | 2 |
| PharmaCyte Biotech | 2 |
PULM News
- 8 days ago - Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities - PRNewsWire
- 12 days ago - Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PRNewsWire
- 5 months ago - Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PRNewsWire
- 7 months ago - Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets - PRNewsWire
- 10 months ago - Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets - PRNewsWire
- 10 months ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 1 year ago - Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PRNewsWire